MyAverix Finance
SHG · Healthcare
Beijing Konruns Pharmaceutical Co Ltd (603590)
Biotechnology
Beijing Konruns Pharmaceutical Co Ltd (603590) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $5.85B, P/E ratio is 102.11, net margin is 6.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603590
Beijing Konruns Pharmaceutical Co Ltd (603590) — FAQ
What is Beijing Konruns Pharmaceutical Co Ltd's market cap?
Beijing Konruns Pharmaceutical Co Ltd (603590) has a reported market cap of $5.85B (data as of 2026-03-29).
What is 603590's P/E ratio?
The price-to-earnings (P/E) ratio for Beijing Konruns Pharmaceutical Co Ltd (603590) is 102.11 (data as of 2026-03-29).
Does Beijing Konruns Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Beijing Konruns Pharmaceutical Co Ltd (603590). Check the MyAverix Finance app for the latest dividend data.
What sector is Beijing Konruns Pharmaceutical Co Ltd in?
Beijing Konruns Pharmaceutical Co Ltd (603590) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 603590 listed on?
603590 is listed on SHG.
What is Beijing Konruns Pharmaceutical Co Ltd's net margin?
Beijing Konruns Pharmaceutical Co Ltd (603590) reports a net margin of 6.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.